Business

Lupin Pharmaceuticals has announced the launch of the InspiraChamber valved holding chamber after it acquired exclusive US rights to the device from InspiRX. The InspiraChamber is being sold as part of a package with pediatric face masks, including the SootherMask, which has a slot for a pacifier. InspiRX CEO Michael Amato commented, "The agreement enables the … [Read more...] about Lupin begins selling valved holding chamber licensed from InspiRX in the US

The United States Court of Appeals for the Federal Circuit has granted AstraZeneca's request for a temporary injunction stopping Actavis from further sales of its budesonide inhalation suspension, according to Actavis. AstraZeneca has appealed the decision earlier this month that ruled US Patent No. 7,524,834 was invalid, after which Actavis announced the launch of … [Read more...] about AstraZeneca gets temporary injunction to stop Actavis sales of generic version of Pulmicort Respules

Lupin Limited and Polish biopharmaceutical company Celon Pharma have announced that they will co-develop a generic version of GSK's Advair Diskus. Celon, which currently markets a fluticasone/salmeterol DPI called Salmex in Poland, will supply the the product to Lupin, and Lupin will commercialize the product in North America and "other key markets." Lupin CEO … [Read more...] about Celon Pharma and Lupin team up to develop fluticasone/salmeterol DPI

Actavis has announced that after the United States District Court for the District of New Jersey denied AstraZeneca's request for a permanent injunction and ruled that US Patent No. 7,524,834 is invalid, Actavis launched its generic version of AstraZeneca's Pulmicort Respules budesonide inhalation suspension in 0.25 and 0.5 mg vials. The FDA approved Actavis's ANDA … [Read more...] about Actavis launches generic version of Pulmicort Respules

GSK has relied heavily on social media to get out the word that its Flonase fluticasone propionate nasal spray is now available over the counter in the United States. The FDA approved Flonase OTC in July 2014. On February 4, 2015, Flonase Twitter and Facebook accounts announced the availability of the … [Read more...] about Flonase now available over the counter in the US

Innovus Pharmaceuticals has announced that the acquisition of Novalere FP and its FlutiCare fluticasone propionate nasal spray. According to documents related to the merger filed with the US Securities and Exchange Commission (SEC), Novalere FP filed an ANDA for the product with the FDA in November 2014. The company says that it expects that the ANDA "may be approved … [Read more...] about Innovus Pharmaceuticals acquires fluticasone nasal spray

AstraZeneca will pay Actavis $600 million plus royalties for US and Canadian rights to Daliresp roflumilast and the Tudorza Pressair aclidinium bromide DPI, plus development rights to an aclidinium/formoterol DPI which was approved in Europe as Duaklir Genuair. AstraZeneca acquired Almirall's respiratory portfolio in 2014. Almirall had licensed US rights to … [Read more...] about AstraZeneca acquires Tudorza Pressair, other Actavis respiratory drugs in US and Canada